Long-term results of Dana-Farber Cancer Institute ALL Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1985–2000)

The Dana-Farber Cancer Institute (DFCI) ALL Consortium has been conducting multi-institutional clinical trials in childhood ALL since 1981. The treatment backbone has included 20–30 consecutive weeks of asparaginase during intensification and frequent vincristine/corticosteroid pulses during the con...

Descripción completa

Detalles Bibliográficos
Autores principales: Silverman, Lewis B., Stevenson, Kristen E., O’Brien, Jane E., Asselin, Barbara L., Barr, Ronald D., Clavell, Luis, Cole, Peter D., Kelly, Kara, Laverdiere, Caroline, Michon, Bruno, Schorin, Marshall A., Schwartz, Cindy L., O’Holleran, Eileen Whyte, Neuberg, Donna S., Cohen, Harvey J., Sallan, Stephen E.
Formato: Texto
Lenguaje:English
Publicado: 2009
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2820141/
https://www.ncbi.nlm.nih.gov/pubmed/20016537
http://dx.doi.org/10.1038/leu.2009.253

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2820141/
https://www.ncbi.nlm.nih.gov/pubmed/20016537
http://dx.doi.org/10.1038/leu.2009.253

Ejemplares similares